Maintenance rituximab in Veterans with follicular lymphoma

Real‐world practice patterns and clinical outcomes in patients with follicular lymphoma (FL), including the adoption of maintenance rituximab (MR) therapy in the United States (US), have been reported in few studies since the release of the National LymphoCare Study almost a decade ago. We analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Halwani, Ahmad S., Rasmussen, Kelli M., Patil, Vikas, Morreall, Deborah, Li, Catherine, Yong, Christina, Burningham, Zachary, Dawson, Keith, Masaquel, Anthony, Henderson, Kevin, DeLong‐Sieg, Elisha, Sauer, Brian C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571803/
https://www.ncbi.nlm.nih.gov/pubmed/32860335
http://dx.doi.org/10.1002/cam4.3420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571803/
https://www.ncbi.nlm.nih.gov/pubmed/32860335
http://dx.doi.org/10.1002/cam4.3420

Ejemplares similares